Area of research
Cancer Research · Genetics
Research interest
Research interests include Breast Cancer Treatment Studies, Estrogen and related hormone effects, Advanced Breast Cancer Therapies, and HER2/EGFR in Cancer Research.
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination
Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy
Benign Breast Disease and the Risk of Breast Cancer
Alliance A061202. a Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib Versus Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Refractory to Lenalidomide and Proteasome Inhibitor Based Therapy: Phase I Results
Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies
CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations
Whole-genome analysis informs breast cancer response to aromatase inhibition